Peter Johnsen

Peter Holger Johnsen, MD, is an Internal Medicine physician at the University Hospital of North Norway, Harstad, Norway. He states that myalgic encephalomyelitis/ chronic fatigue syndrome may be caused by a disorder in the natural intestinal flora possibly from a leak of bacterial products from the intestine.

Dr Johnsen is conducting a clinical trial funded by the Norwegian Health Council on the use of fecal microbiota transplant (FMT) on the treatment of myalgic encephalomyelitis/ chronic fatigue syndrome.

Notable studies

• 2017, Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial (Abstract)

Talks and interviews

• 1 Jun 2018, Speaker at the 13th Invest in ME International ME Conference on "Double blinded, single center, placebo controlled, randomized clinical trial treating ME with FMT"

Online presence

• ResearchGate

Learn more

• Forskningsjubel for tarmprosjekt for ME-syke (Research appeals for intestinal care for ME patients)

See also

• Fecal microbiota transplant

microbiome The full collection of microscopic organisms (especially bacteria and fungi) which are present in a particular environment, particularly inside the human body.

double blinded trial A clinical trial is double blinded if neither the participants nor the researchers know which treatment group they are allocated to until after the results are interpreted. This reduces bias. (Learn more: www.nottingham.ac.uk)

blinded trial A clinical trial is blinded if either the participants or the researchers don't know which treatment group they are allocated to until after the results are interpreted. (Learn more: www.nottingham.ac.uk)